Drug Approval | August 28, 2023
Briefs: Granules India
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The inspection closed with zero observations and a classification of No Action Indicated
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
The product basket increased to 1800 medicines and 285 Surgical Equipment
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Aurobindo will respond to the US FDA within the stipulated timelines
With close to 30-40 basic screening tests available, the unit encompasses all the essential parameters typically covered in annual health check-ups
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Subscribe To Our Newsletter & Stay Updated
